Frede Donskov

168 posts

Frede Donskov

Frede Donskov

@FDonskov

Clinical Professor in Oncology, University Hospital of Southern Denmark, Esbjerg, Denmark.

انضم Aralık 2019
240 يتبع238 المتابعون
Frede Donskov أُعيد تغريده
Milan Hora
Milan Hora@milanhoraplzen·
Cytoreductive nephrectomy associated with longer OS in patients with #mRCC treated with immune checkpoint inhibitor (ICI) therapy in any line of therapy. A multicenter retrospective cohort study of 367 patients (CN+ST 232, ST alone 135). sciencedirect.com/science/articl…
Milan Hora tweet mediaMilan Hora tweet media
Vejprnice, Česká republika 🇨🇿 English
5
44
157
0
Frede Donskov
Frede Donskov@FDonskov·
@KidneyCancer Sad news. Nicholas Vogelzang was a pioneer, a true leader, and a nice person!
English
0
0
2
0
Kidney Cancer
Kidney Cancer@KidneyCancer·
We are sad to announce Dr. Nicholas J. Vogelzang, co-founder of the KCA, died on September 20th. The KCA became a reality around Dr. Vogelzang's kitchen table in 1990 and he remained a dynamic and steadfast supporter of the organization and its mission throughout his life. 1/2
Kidney Cancer tweet media
English
19
38
167
0
Frede Donskov أُعيد تغريده
Myriam Chalabi
Myriam Chalabi@MyriamChalabi·
About the smile: the standing ovation also meant that people saw what I knew: behind every one of these bars is a patient. I know every name and have seen almost everyone. I know their stories and their children. And I believe many are cured because of this. #ESMO22 #ChalabiPlot
Myriam Chalabi tweet media
English
34
252
1.9K
0
Frede Donskov أُعيد تغريده
Toni Choueiri, MD
Toni Choueiri, MD@DrChoueiri·
A waterfall plot or a tidal wave 🌊???? 🤩 😯 99% pathologic response with nivo/ipi in dMMR CRC and NO disease recurrences!! #ESMO22@myESMO⁩ ⁦@MyriamChalabi
Toni Choueiri, MD tweet media
English
12
125
567
0
Frede Donskov
Frede Donskov@FDonskov·
Important study published. Leibovich and GRANT validated in ccRCC and non-ccRCC nationwide #kidneycancer cohort. Leibovich outperformed GRANT in predicting recurrence-free survival and should remain standard approach to risk stratify patients. @oncoalert doi.org/10.1111/iju.14…
Yüksel Ürün@DrYukselUrun

Do we have a Litmus test to predict survival in localized kidney cancer? 🔸7653 patients: GRade, Age, Nodes, and Tumor score (GRANT) 🇩🇰 🔸Leibovich score outperformed the GRANT regarding RFS @FDonskov @OncoAlert @Uroweb @urotoday @NessnAzawi @KidneyCancer onlinelibrary.wiley.com/doi/10.1111/ij…

English
0
3
10
0